BioSpace News Archive

Acquisition will expand structural heart portfolio to include transcatheter mitral annuloplasty repair system

Company plans to expand its WeedPass rewards program to San Francisco and Phoenix markets in early 2019

Pliant Therapeutics, Inc. today announced that Bernard Coulie, M.D., Ph.D., president and chief executive officer, will present at the 37th Annual J.P. Morgan Healthcare Conference. Dr. Coulie’s presentation will take place at 9:00 a.m. PST on Wednesday, January 9, 2019, at the Westin St. Francis in San Francisco, Calif.

Subject to NMPA acceptance, Bio-Thera Solutions plans to initiate the Phase I clinical trial early in 2019.

According to the Journal of the Royal Society of Medicine, approximately 80 percent of patients fail to recall medical information provided by their doctor.

OWC announced today that management will attend Biotech Showcase 2019 to be held in San Francisco, CA on January 7-9, 2019.

Dr. Hanan Polansky from the CBCD published a new paper titled: “How latent viruses cause breast cancer: An explanation based on the microcompetition model.”

It’s estimated that 4 out of 5 adults will have an attack of back pain at some point in their lives.

UMN researcher/physician studies how children cured of cancer are at risk for developing a second cancer later in life

Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced the results from a large commercial cohort and several clinical studies on development of the adjusted Vectra® score that were published in the journal Rheumatology.